Bio

David Bassett is a nationally recognized intellectual property litigation lawyer. He is based in the firm’s New York office and is the former chair of the firm’s Associates Committee and of the firm’s Intellectual Property Litigation Practice. Mr. Bassett's practice concentrates on intellectual property litigation, particularly on biotechnology, pharmaceutical and Hatch-Waxman patent disputes. He also represents clients in a wide variety of other business disputes, including breach of contract, Lanham Act and Internet-related claims. His intellectual property litigation clients have included Gilead Sciences, Shionogi, Foundation Medicine, Precision BioScience, Actavis, Braintree Laboratories, Forest (Allergan) and many others. His practice has covered all facets of litigation, including discovery, settlement, alternative dispute resolution, IPRs, trials and appeals. Mr. Bassett has been lead trial lawyer in more than a dozen patent trials (both bench and jury), and has appeared before the Courts of Appeals for the First and Federal Circuits. He has been recognized as a leading lawyer in Chambers USA, Best Lawyers in America, LMG Life Sciences and IAM Patent 1000.